Egenskap
Fatigue
A subjective feeling of tiredness characterized by a lack of energy and motivation.
Sammendrag
- Også kalt
- Tired, Tiredness
- Kroppssystem
- Constitutional symptom
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Fatigue, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test501 gener knyttet til Fatigue
Endringer i disse genene forårsaker sjeldne tilstander der Fatigue forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ABCC9ATP binding cassette subfamily C member 9 | Alltid | I 3 tilstander |
| ALBalbumin | Alltid | I 2 tilstander |
| CST3cystatin C | Alltid | I 1 tilstand |
| EMDemerin | Alltid | I 1 tilstand |
| FDXRferredoxin reductase | Alltid | I 1 tilstand |
| FLT3LGfms related receptor tyrosine kinase 3 ligand | Alltid | I 1 tilstand |
| GAAalpha glucosidase | Alltid | I 1 tilstand |
| GFAPglial fibrillary acidic protein | Alltid | I 1 tilstand |
| GYS1glycogen synthase 1 | Alltid | I 1 tilstand |
| HEPHL1hephaestin like 1 | Alltid | I 1 tilstand |
| IL18BPinterleukin 18 binding protein | Alltid | I 1 tilstand |
| IL21interleukin 21 | Alltid | I 1 tilstand |
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Alltid | I 1 tilstand |
| JPH1junctophilin 1 | Alltid | I 1 tilstand |
| KLklotho | Alltid | I 1 tilstand |
| KLF1KLF transcription factor 1 | Alltid | I 1 tilstand |
| LMNAlamin A/C | Alltid | I 2 tilstander |
| LRIF1ligand dependent nuclear receptor interacting factor 1 | Alltid | I 1 tilstand |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Alltid | I 1 tilstand |
| MAU2MAU2 sister chromatid cohesion factor | Alltid | I 1 tilstand |
| NDC1NDC1 transmembrane nucleoporin | Alltid | I 1 tilstand |
| NEXNnexilin F-actin binding protein | Alltid | I 2 tilstander |
| NLRC4NLR family CARD domain containing 4 | Alltid | I 1 tilstand |
| NOTCH3notch receptor 3 | Alltid | I 1 tilstand |
| NRAPnebulin related anchoring protein | Alltid | I 2 tilstander |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Alltid | I 1 tilstand |
| PIK3CGphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | Alltid | I 1 tilstand |
| PLEKHM1pleckstrin homology and RUN domain containing M1 | Alltid | I 1 tilstand |
| PNPLA8patatin like domain 8, phospholipase A2 | Alltid | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Alltid | I 2 tilstander |
| PTCRApre T cell antigen receptor alpha | Alltid | I 1 tilstand |
| PTPMT1protein tyrosine phosphatase mitochondrial 1 | Alltid | I 1 tilstand |
| RIN2Ras and Rab interactor 2 | Alltid | I 1 tilstand |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Alltid | I 2 tilstander |
| SLC18A2solute carrier family 18 member A2 | Alltid | I 2 tilstander |
| SLC25A4solute carrier family 25 member 4 | Alltid | I 2 tilstander |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Alltid | I 2 tilstander |
| THRBthyroid hormone receptor beta | Alltid | I 1 tilstand |
| ZMYM3zinc finger MYM-type containing 3 | Alltid | I 1 tilstand |
| AIPAHR interacting HSP90 co-chaperone | Svært ofte (80–99 %) | I 2 tilstander |
Vis 461 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ALAS25'-aminolevulinate synthase 2 | Svært ofte (80–99 %) | I 1 tilstand |
| ATMATM serine/threonine kinase | Svært ofte (80–99 %) | I 2 tilstander |
| ATP7AATPase copper transporting alpha | Svært ofte (80–99 %) | I 1 tilstand |
| ATRXATRX chromatin remodeler | Svært ofte (80–99 %) | I 1 tilstand |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Svært ofte (80–99 %) | I 1 tilstand |
| BCL10BCL10 immune signaling adaptor | Svært ofte (80–99 %) | I 1 tilstand |
| BIRC3baculoviral IAP repeat containing 3 | Svært ofte (80–99 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Svært ofte (80–99 %) | I 1 tilstand |
| BLNKB cell linker | Svært ofte (80–99 %) | I 1 tilstand |
| BMPR1Abone morphogenetic protein receptor type 1A | Svært ofte (80–99 %) | I 1 tilstand |
| BRCA2BRCA2 DNA repair associated | Svært ofte (80–99 %) | I 2 tilstander |
| BTKBruton tyrosine kinase | Svært ofte (80–99 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Svært ofte (80–99 %) | I 2 tilstander |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Svært ofte (80–99 %) | I 1 tilstand |
| CALRcalreticulin | Svært ofte (80–99 %) | I 2 tilstander |
| CCR1C-C motif chemokine receptor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| CD4CD4 molecule | Svært ofte (80–99 %) | I 1 tilstand |
| CD79ACD79a molecule | Svært ofte (80–99 %) | I 1 tilstand |
| CD79BCD79b molecule | Svært ofte (80–99 %) | I 1 tilstand |
| CHEK2checkpoint kinase 2 | Svært ofte (80–99 %) | I 1 tilstand |
| CPT1Acarnitine palmitoyltransferase 1A | Svært ofte (80–99 %) | I 1 tilstand |
| CR2complement C3d receptor 2 | Svært ofte (80–99 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Svært ofte (80–99 %) | I 2 tilstander |
| DDB2damage specific DNA binding protein 2 | Svært ofte (80–99 %) | I 1 tilstand |
| DNASE1deoxyribonuclease 1 | Svært ofte (80–99 %) | I 1 tilstand |
| EPCAMepithelial cell adhesion molecule | Svært ofte (80–99 %) | I 1 tilstand |
| EPORerythropoietin receptor | Svært ofte (80–99 %) | I 2 tilstander |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Svært ofte (80–99 %) | I 1 tilstand |
| ERCC3ERCC excision repair 3, TFIIH core complex helicase subunit | Svært ofte (80–99 %) | I 1 tilstand |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Svært ofte (80–99 %) | I 1 tilstand |
| ERCC5ERCC excision repair 5, endonuclease | Svært ofte (80–99 %) | I 1 tilstand |
| ETS1ETS proto-oncogene 1, transcription factor | Svært ofte (80–99 %) | I 1 tilstand |
| FASFas cell surface death receptor | Svært ofte (80–99 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Svært ofte (80–99 %) | I 1 tilstand |
| FCGR3BFc gamma receptor IIIb | Svært ofte (80–99 %) | I 1 tilstand |
| FOXE1forkhead box E1 | Svært ofte (80–99 %) | I 1 tilstand |
| FOXP1forkhead box P1 | Svært ofte (80–99 %) | I 1 tilstand |
| GATA2GATA binding protein 2 | Svært ofte (80–99 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Svært ofte (80–99 %) | I 1 tilstand |
| GLAgalactosidase alpha | Svært ofte (80–99 %) | I 1 tilstand |
| GPR101G protein-coupled receptor 101 | Svært ofte (80–99 %) | I 1 tilstand |
| HBA1hemoglobin subunit alpha 1 | Svært ofte (80–99 %) | I 1 tilstand |
| HBA2hemoglobin subunit alpha 2 | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Svært ofte (80–99 %) | I 4 tilstander |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Svært ofte (80–99 %) | I 2 tilstander |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Svært ofte (80–99 %) | I 5 tilstander |
| HNF4Ahepatocyte nuclear factor 4 alpha | Svært ofte (80–99 %) | I 1 tilstand |
| IFNGR1interferon gamma receptor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IGHimmunoglobulin heavy locus | Svært ofte (80–99 %) | I 3 tilstander |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Svært ofte (80–99 %) | I 1 tilstand |
| IGHMimmunoglobulin heavy constant mu | Svært ofte (80–99 %) | I 1 tilstand |
| IGLL1immunoglobulin lambda like polypeptide 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IKZF1IKAROS family zinc finger 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Svært ofte (80–99 %) | I 3 tilstander |
| IL12Ainterleukin 12A | Svært ofte (80–99 %) | I 2 tilstander |
| IL12A-AS1IL12A antisense RNA 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IL12Binterleukin 12B | Svært ofte (80–99 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Svært ofte (80–99 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Svært ofte (80–99 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Svært ofte (80–99 %) | I 2 tilstander |
| ITGAMintegrin subunit alpha M | Svært ofte (80–99 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Svært ofte (80–99 %) | I 4 tilstander |
| JAZF1JAZF zinc finger 1 | Svært ofte (80–99 %) | I 1 tilstand |
| KIAA0319LKIAA0319 like | Svært ofte (80–99 %) | I 1 tilstand |
| KLRC4killer cell lectin like receptor C4 | Svært ofte (80–99 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Svært ofte (80–99 %) | I 1 tilstand |
| LBRlamin B receptor | Svært ofte (80–99 %) | I 1 tilstand |
| LRRC8Aleucine rich repeat containing 8 VRAC subunit A | Svært ofte (80–99 %) | I 1 tilstand |
| MALT1MALT1 paracaspase | Svært ofte (80–99 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Svært ofte (80–99 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Svært ofte (80–99 %) | I 2 tilstander |
| MLH1mutL homolog 1 | Svært ofte (80–99 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Svært ofte (80–99 %) | I 1 tilstand |
| MMADHCmetabolism of cobalamin associated D | Svært ofte (80–99 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Svært ofte (80–99 %) | I 2 tilstander |
| MSH2mutS homolog 2 | Svært ofte (80–99 %) | I 1 tilstand |
| MSH6mutS homolog 6 | Svært ofte (80–99 %) | I 1 tilstand |
| MUTYHmutY DNA glycosylase | Svært ofte (80–99 %) | I 1 tilstand |
| MYH7myosin heavy chain 7 | Svært ofte (80–99 %) | I 2 tilstander |
| NFKB2nuclear factor kappa B subunit 2 | Svært ofte (80–99 %) | I 1 tilstand |
| NKX2-1NK2 homeobox 1 | Svært ofte (80–99 %) | I 1 tilstand |
| NKX2-5NK2 homeobox 5 | Svært ofte (80–99 %) | I 4 tilstander |
| NLRP3NLR family pyrin domain containing 3 | Svært ofte (80–99 %) | I 3 tilstander |
| NPATnuclear protein, coactivator of histone transcription | Svært ofte (80–99 %) | I 1 tilstand |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Svært ofte (80–99 %) | I 2 tilstander |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Svært ofte (80–99 %) | I 1 tilstand |
| PABPN1poly(A) binding protein nuclear 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PAX8paired box 8 | Svært ofte (80–99 %) | I 3 tilstander |
| PDCD1programmed cell death 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Svært ofte (80–99 %) | I 1 tilstand |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Svært ofte (80–99 %) | I 1 tilstand |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PMS1PMS1 homolog 1, mismatch repair system component | Svært ofte (80–99 %) | I 1 tilstand |
| PMS2PMS1 homolog 2, mismatch repair system component | Svært ofte (80–99 %) | I 1 tilstand |
| POLD1DNA polymerase delta 1, catalytic subunit | Svært ofte (80–99 %) | I 1 tilstand |
| POLEDNA polymerase epsilon, catalytic subunit | Svært ofte (80–99 %) | I 1 tilstand |
| PRTN3proteinase 3 | Svært ofte (80–99 %) | I 1 tilstand |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Svært ofte (80–99 %) | I 3 tilstander |
| PXKPX domain containing serine/threonine kinase like | Svært ofte (80–99 %) | I 1 tilstand |
| RPS20ribosomal protein S20 | Svært ofte (80–99 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Svært ofte (80–99 %) | I 5 tilstander |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Svært ofte (80–99 %) | I 4 tilstander |
| SDHCsuccinate dehydrogenase complex subunit C | Svært ofte (80–99 %) | I 3 tilstander |
| SEMA4Asemaphorin 4A | Svært ofte (80–99 %) | I 1 tilstand |
| SH2B3SH2B adaptor protein 3 | Svært ofte (80–99 %) | I 2 tilstander |
| SLC26A4solute carrier family 26 member 4 | Svært ofte (80–99 %) | I 2 tilstander |
| SPI1Spi-1 proto-oncogene | Svært ofte (80–99 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Svært ofte (80–99 %) | I 2 tilstander |
| TBX19T-box transcription factor 19 | Svært ofte (80–99 %) | I 1 tilstand |
| TCF3transcription factor 3 | Svært ofte (80–99 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Svært ofte (80–99 %) | I 5 tilstander |
| TGFBR2transforming growth factor beta receptor 2 | Svært ofte (80–99 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Svært ofte (80–99 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Svært ofte (80–99 %) | I 1 tilstand |
| TNIP1TNFAIP3 interacting protein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| TP53tumor protein p53 | Svært ofte (80–99 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Svært ofte (80–99 %) | I 1 tilstand |
| TSHRthyroid stimulating hormone receptor | Svært ofte (80–99 %) | I 2 tilstander |
| UBAC2UBA domain containing 2 | Svært ofte (80–99 %) | I 1 tilstand |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Svært ofte (80–99 %) | I 1 tilstand |
| XPAXPA, DNA damage recognition and repair factor | Svært ofte (80–99 %) | I 1 tilstand |
| XPCXPC complex subunit, DNA damage recognition and repair factor | Svært ofte (80–99 %) | I 1 tilstand |
| ABCA3ATP binding cassette subfamily A member 3 | Ofte (30–79 %) | I 1 tilstand |
| ABCD1ATP binding cassette subfamily D member 1 | Ofte (30–79 %) | I 1 tilstand |
| ABL1ABL proto-oncogene 1, non-receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| ACTA1actin alpha 1, skeletal muscle | Ofte (30–79 %) | I 1 tilstand |
| ACTC1actin alpha cardiac muscle 1 | Ofte (30–79 %) | I 2 tilstander |
| ACTN2actinin alpha 2 | Ofte (30–79 %) | I 1 tilstand |
| ADGRV1adhesion G protein-coupled receptor V1 | Ofte (30–79 %) | I 1 tilstand |
| ALKALK receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| ANGangiogenin | Ofte (30–79 %) | I 1 tilstand |
| ANKRD1ankyrin repeat domain 1 | Ofte (30–79 %) | I 1 tilstand |
| ANXA11annexin A11 | Ofte (30–79 %) | I 1 tilstand |
| AP1S3adaptor related protein complex 1 subunit sigma 3 | Ofte (30–79 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 2 tilstander |
| ATP11AATPase phospholipid transporting 11A | Ofte (30–79 %) | I 1 tilstand |
| ATP13A2ATPase cation transporting 13A2 | Ofte (30–79 %) | I 3 tilstander |
| ATXN2ataxin 2 | Ofte (30–79 %) | I 1 tilstand |
| BAG3BAG cochaperone 3 | Ofte (30–79 %) | I 1 tilstand |
| BAG5BAG cochaperone 5 | Ofte (30–79 %) | I 1 tilstand |
| BCL2BCL2 apoptosis regulator | Ofte (30–79 %) | I 1 tilstand |
| BCL6BCL6 transcription repressor | Ofte (30–79 %) | I 1 tilstand |
| BCORBCL6 corepressor | Ofte (30–79 %) | I 1 tilstand |
| BCRBCR activator of RhoGEF and GTPase | Ofte (30–79 %) | I 1 tilstand |
| BMP6bone morphogenetic protein 6 | Ofte (30–79 %) | I 1 tilstand |
| BRCA1BRCA1 DNA repair associated | Ofte (30–79 %) | I 1 tilstand |
| BTNL2butyrophilin like 2 | Ofte (30–79 %) | I 1 tilstand |
| CAP2cyclase associated actin cytoskeleton regulatory protein 2 | Ofte (30–79 %) | I 1 tilstand |
| CARMIL2capping protein regulator and myosin 1 linker 2 | Ofte (30–79 %) | I 1 tilstand |
| CBLCbl proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| CCND1cyclin D1 | Ofte (30–79 %) | I 2 tilstander |
| CCNFcyclin F | Ofte (30–79 %) | I 1 tilstand |
| CD46CD46 molecule | Ofte (30–79 %) | I 1 tilstand |
| CDC73cell division cycle 73 | Ofte (30–79 %) | I 2 tilstander |
| CDH23cadherin related 23 | Ofte (30–79 %) | I 2 tilstander |
| CFAP410cilia and flagella associated protein 410 | Ofte (30–79 %) | I 1 tilstand |
| CFHcomplement factor H | Ofte (30–79 %) | I 1 tilstand |
| CFIcomplement factor I | Ofte (30–79 %) | I 1 tilstand |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Ofte (30–79 %) | I 1 tilstand |
| CHMP2Bcharged multivesicular body protein 2B | Ofte (30–79 %) | I 1 tilstand |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Ofte (30–79 %) | I 2 tilstander |
| CLCN7Cl-/H+ antiporter 7 | Ofte (30–79 %) | I 1 tilstand |
| COL1A1collagen type I alpha 1 chain | Ofte (30–79 %) | I 1 tilstand |
| COL5A1collagen type V alpha 1 chain | Ofte (30–79 %) | I 1 tilstand |
| COL5A2collagen type V alpha 2 chain | Ofte (30–79 %) | I 1 tilstand |
| COL9A2collagen type IX alpha 2 chain | Ofte (30–79 %) | I 1 tilstand |
| CRYABcrystallin alpha B | Ofte (30–79 %) | I 1 tilstand |
| CSRP3cysteine and glycine rich protein 3 | Ofte (30–79 %) | I 1 tilstand |
| CTNNB1catenin beta 1 | Ofte (30–79 %) | I 1 tilstand |
| DAOD-amino acid oxidase | Ofte (30–79 %) | I 1 tilstand |
| DBHdopamine beta-hydroxylase | Ofte (30–79 %) | I 1 tilstand |
| DCTN1dynactin subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| DESdesmin | Ofte (30–79 %) | I 1 tilstand |
| DLSTdihydrolipoamide S-succinyltransferase | Ofte (30–79 %) | I 1 tilstand |
| DMDdystrophin | Ofte (30–79 %) | I 2 tilstander |
| DNAJC6DnaJ heat shock protein family (Hsp40) member C6 | Ofte (30–79 %) | I 1 tilstand |
| DNMT3ADNA methyltransferase 3 alpha | Ofte (30–79 %) | I 1 tilstand |
| DOLKdolichol kinase | Ofte (30–79 %) | I 1 tilstand |
| DPP9dipeptidyl peptidase 9 | Ofte (30–79 %) | I 1 tilstand |
| DSG2desmoglein 2 | Ofte (30–79 %) | I 1 tilstand |
| DSPdesmoplakin | Ofte (30–79 %) | I 2 tilstander |
| ELANEelastase, neutrophil expressed | Ofte (30–79 %) | I 1 tilstand |
| EPAS1endothelial PAS domain protein 1 | Ofte (30–79 %) | I 1 tilstand |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Ofte (30–79 %) | I 1 tilstand |
| FAM13Afamily with sequence similarity 13 member A | Ofte (30–79 %) | I 1 tilstand |
| FGF23fibroblast growth factor 23 | Ofte (30–79 %) | I 1 tilstand |
| FHfumarate hydratase | Ofte (30–79 %) | I 1 tilstand |
| FHL2four and a half LIM domains 2 | Ofte (30–79 %) | I 1 tilstand |
| FIG4FIG4 phosphoinositide 5-phosphatase | Ofte (30–79 %) | I 1 tilstand |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Ofte (30–79 %) | I 1 tilstand |
| FKTNfukutin | Ofte (30–79 %) | I 1 tilstand |
| FLNCfilamin C | Ofte (30–79 %) | I 1 tilstand |
| FOXA2forkhead box A2 | Ofte (30–79 %) | I 1 tilstand |
| FUSFUS RNA binding protein | Ofte (30–79 %) | I 1 tilstand |
| GATA4GATA binding protein 4 | Ofte (30–79 %) | I 2 tilstander |
| GATA5GATA binding protein 5 | Ofte (30–79 %) | I 1 tilstand |
| GATA6GATA binding protein 6 | Ofte (30–79 %) | I 2 tilstander |
| GATAD1GATA zinc finger domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| GCH1GTP cyclohydrolase 1 | Ofte (30–79 %) | I 1 tilstand |
| GCKglucokinase | Ofte (30–79 %) | I 1 tilstand |
| GET3guided entry of tail-anchored proteins factor 3, ATPase | Ofte (30–79 %) | I 1 tilstand |
| GJA5gap junction protein alpha 5 | Ofte (30–79 %) | I 1 tilstand |
| GLE1GLE1 RNA export mediator | Ofte (30–79 %) | I 1 tilstand |
| GLI2GLI family zinc finger 2 | Ofte (30–79 %) | I 1 tilstand |
| GLT8D1glycosyltransferase 8 domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| HACD13-hydroxyacyl-CoA dehydratase 1 | Ofte (30–79 %) | I 1 tilstand |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Ofte (30–79 %) | I 1 tilstand |
| HAND2heart and neural crest derivatives expressed 2 | Ofte (30–79 %) | I 1 tilstand |
| HAVCR2hepatitis A virus cellular receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| HELLPARHELLP associated long non-coding RNA | Ofte (30–79 %) | I 1 tilstand |
| HESX1HESX homeobox 1 | Ofte (30–79 %) | I 3 tilstander |
| HFEhomeostatic iron regulator | Ofte (30–79 %) | I 1 tilstand |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Ofte (30–79 %) | I 1 tilstand |
| IL36RNinterleukin 36 receptor antagonist | Ofte (30–79 %) | I 1 tilstand |
| IMPDH2inosine monophosphate dehydrogenase 2 | Ofte (30–79 %) | I 1 tilstand |
| INSRinsulin receptor | Ofte (30–79 %) | I 1 tilstand |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| ITGA7integrin subunit alpha 7 | Ofte (30–79 %) | I 1 tilstand |
| JPH2junctophilin 2 | Ofte (30–79 %) | I 1 tilstand |
| KCNA5potassium voltage-gated channel subfamily A member 5 | Ofte (30–79 %) | I 1 tilstand |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Ofte (30–79 %) | I 1 tilstand |
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Ofte (30–79 %) | I 1 tilstand |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Ofte (30–79 %) | I 1 tilstand |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Ofte (30–79 %) | I 1 tilstand |
| KIF1Bkinesin family member 1B | Ofte (30–79 %) | I 1 tilstand |
| KIF23kinesin family member 23 | Ofte (30–79 %) | I 1 tilstand |
| KITKIT proto-oncogene, receptor tyrosine kinase | Ofte (30–79 %) | I 2 tilstander |
| LAMA4laminin subunit alpha 4 | Ofte (30–79 %) | I 1 tilstand |
| LDB3LIM domain binding 3 | Ofte (30–79 %) | I 1 tilstand |
| LHX3LIM homeobox 3 | Ofte (30–79 %) | I 1 tilstand |
| LHX4LIM homeobox 4 | Ofte (30–79 %) | I 2 tilstander |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Ofte (30–79 %) | I 1 tilstand |
| LMO1LIM domain only 1 | Ofte (30–79 %) | I 1 tilstand |
| LMOD2leiomodin 2 | Ofte (30–79 %) | I 1 tilstand |
| LRP12LDL receptor related protein 12 | Ofte (30–79 %) | I 1 tilstand |
| MAP3K20mitogen-activated protein kinase kinase kinase 20 | Ofte (30–79 %) | I 1 tilstand |
| MATR3matrin 3 | Ofte (30–79 %) | I 1 tilstand |
| MAXMYC associated transcriptional regulator X | Ofte (30–79 %) | I 1 tilstand |
| MDH2malate dehydrogenase 2 | Ofte (30–79 %) | I 1 tilstand |
| MEN1menin 1 | Ofte (30–79 %) | I 2 tilstander |
| METMET proto-oncogene, receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| MORC2MORC family CW-type zinc finger 2 | Ofte (30–79 %) | I 1 tilstand |
| MUC5Bmucin 5B, oligomeric mucus/gel-forming | Ofte (30–79 %) | I 1 tilstand |
| MYBPC3myosin binding protein C3 | Ofte (30–79 %) | I 1 tilstand |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Ofte (30–79 %) | I 1 tilstand |
| MYH6myosin heavy chain 6 | Ofte (30–79 %) | I 2 tilstander |
| MYL2myosin light chain 2 | Ofte (30–79 %) | I 1 tilstand |
| MYL4myosin light chain 4 | Ofte (30–79 %) | I 1 tilstand |
| MYO7Amyosin VIIA | Ofte (30–79 %) | I 1 tilstand |
| MYPNmyopalladin | Ofte (30–79 %) | I 1 tilstand |
| MYT1Lmyelin transcription factor 1 like | Ofte (30–79 %) | I 1 tilstand |
| NAA80N-alpha-acetyltransferase 80, NatH catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| NABP1nucleic acid binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| NEFHneurofilament heavy chain | Ofte (30–79 %) | I 1 tilstand |
| NEK1NIMA related kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| NF1neurofibromin 1 | Ofte (30–79 %) | I 1 tilstand |
| NIT1nitrilase 1 | Ofte (30–79 %) | I 1 tilstand |
| NKX2-6NK2 homeobox 6 | Ofte (30–79 %) | I 1 tilstand |
| NPM1nucleophosmin 1 | Ofte (30–79 %) | I 1 tilstand |
| NPPAnatriuretic peptide A | Ofte (30–79 %) | I 2 tilstander |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Ofte (30–79 %) | I 1 tilstand |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Ofte (30–79 %) | I 1 tilstand |
| NUMA1nuclear mitotic apparatus protein 1 | Ofte (30–79 %) | I 1 tilstand |
| NUP155nucleoporin 155 | Ofte (30–79 %) | I 1 tilstand |
| OPA1OPA1 mitochondrial dynamin like GTPase | Ofte (30–79 %) | I 2 tilstander |
| OPTNoptineurin | Ofte (30–79 %) | I 1 tilstand |
| OTX2orthodenticle homeobox 2 | Ofte (30–79 %) | I 2 tilstander |
| PARNpoly(A)-specific ribonuclease | Ofte (30–79 %) | I 1 tilstand |
| PDGFRAplatelet derived growth factor receptor alpha | Ofte (30–79 %) | I 1 tilstand |
| PDZD7PDZ domain containing 7 | Ofte (30–79 %) | I 1 tilstand |
| PFN1profilin 1 | Ofte (30–79 %) | I 1 tilstand |
| PHIPPHIP subunit of CUL4-Ring ligase complex | Ofte (30–79 %) | I 1 tilstand |
| PHKA1phosphorylase kinase regulatory subunit alpha 1 | Ofte (30–79 %) | I 1 tilstand |
| PHKG1phosphorylase kinase catalytic subunit gamma 1 | Ofte (30–79 %) | I 1 tilstand |
| PHOX2Bpaired like homeobox 2B | Ofte (30–79 %) | I 1 tilstand |
| PITX2paired like homeodomain 2 | Ofte (30–79 %) | I 1 tilstand |
| PLNphospholamban | Ofte (30–79 %) | I 1 tilstand |
| PMLPML nuclear body scaffold | Ofte (30–79 %) | I 1 tilstand |
| PODXLpodocalyxin like | Ofte (30–79 %) | I 1 tilstand |
| POLGDNA polymerase gamma, catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| POLG2DNA polymerase gamma 2, accessory subunit | Ofte (30–79 %) | I 1 tilstand |
| POLR3GLRNA polymerase III subunit GL | Ofte (30–79 %) | I 1 tilstand |
| POU1F1POU class 1 homeobox 1 | Ofte (30–79 %) | I 2 tilstander |
| PPCSphosphopantothenoylcysteine synthetase | Ofte (30–79 %) | I 1 tilstand |
| PRDM16PR/SET domain 16 | Ofte (30–79 %) | I 1 tilstand |
| PREPLprolyl endopeptidase like | Ofte (30–79 %) | I 1 tilstand |
| PROP1PROP paired-like homeobox 1 | Ofte (30–79 %) | I 3 tilstander |
| PRPHperipherin | Ofte (30–79 %) | I 1 tilstand |
| PSEN1presenilin 1 | Ofte (30–79 %) | I 1 tilstand |
| PSEN2presenilin 2 | Ofte (30–79 %) | I 1 tilstand |
| PTPN3protein tyrosine phosphatase non-receptor type 3 | Ofte (30–79 %) | I 1 tilstand |
| RACGAP1Rac GTPase activating protein 1 | Ofte (30–79 %) | I 1 tilstand |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Ofte (30–79 %) | I 1 tilstand |
| RAPSNreceptor associated protein of the synapse | Ofte (30–79 %) | I 1 tilstand |
| RARAretinoic acid receptor alpha | Ofte (30–79 %) | I 1 tilstand |
| RBM20RNA binding motif protein 20 | Ofte (30–79 %) | I 1 tilstand |
| RETret proto-oncogene | Ofte (30–79 %) | I 2 tilstander |
| ROS1ROS proto-oncogene 1, receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| RPL3Lribosomal protein L3 like | Ofte (30–79 %) | I 1 tilstand |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Ofte (30–79 %) | I 2 tilstander |
| RTEL1regulator of telomere elongation helicase 1 | Ofte (30–79 %) | I 1 tilstand |
| RUNX1RUNX family transcription factor 1 | Ofte (30–79 %) | I 2 tilstander |
| RYR1ryanodine receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Ofte (30–79 %) | I 1 tilstand |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Ofte (30–79 %) | I 1 tilstand |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Ofte (30–79 %) | I 3 tilstander |
| SCNN1Asodium channel epithelial 1 subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| SCNN1Bsodium channel epithelial 1 subunit beta | Ofte (30–79 %) | I 1 tilstand |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Ofte (30–79 %) | I 1 tilstand |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Ofte (30–79 %) | I 1 tilstand |
| SDHDsuccinate dehydrogenase complex subunit D | Ofte (30–79 %) | I 2 tilstander |
| SELENONselenoprotein N | Ofte (30–79 %) | I 1 tilstand |
| SFTPA1surfactant protein A1 | Ofte (30–79 %) | I 1 tilstand |
| SFTPA2surfactant protein A2 | Ofte (30–79 %) | I 1 tilstand |
| SFTPCsurfactant protein C | Ofte (30–79 %) | I 1 tilstand |
| SGCDsarcoglycan delta | Ofte (30–79 %) | I 1 tilstand |
| SLC25A11solute carrier family 25 member 11 | Ofte (30–79 %) | I 1 tilstand |
| SLC2A10solute carrier family 2 member 10 | Ofte (30–79 %) | I 1 tilstand |
| SLC34A2solute carrier family 34 member 2 | Ofte (30–79 %) | I 1 tilstand |
| SLC3A1solute carrier family 3 member 1 | Ofte (30–79 %) | I 1 tilstand |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Ofte (30–79 %) | I 1 tilstand |
| SOD1superoxide dismutase 1 | Ofte (30–79 %) | I 1 tilstand |
| SOX17SRY-box transcription factor 17 | Ofte (30–79 %) | I 1 tilstand |
| SOX3SRY-box transcription factor 3 | Ofte (30–79 %) | I 2 tilstander |
| SQSTM1sequestosome 1 | Ofte (30–79 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 2 tilstander |
| STAT3signal transducer and activator of transcription 3 | Ofte (30–79 %) | I 1 tilstand |
| STAT5Bsignal transducer and activator of transcription 5B | Ofte (30–79 %) | I 1 tilstand |
| STEAP3STEAP3 metalloreductase | Ofte (30–79 %) | I 1 tilstand |
| STN1STN1 subunit of CST complex | Ofte (30–79 %) | I 1 tilstand |
| SYNJ1synaptojanin 1 | Ofte (30–79 %) | I 2 tilstander |
| TAF15TATA-box binding protein associated factor 15 | Ofte (30–79 %) | I 1 tilstand |
| TAF1ATATA-box binding protein associated factor, RNA polymerase I subunit A | Ofte (30–79 %) | I 1 tilstand |
| TARDBPTAR DNA binding protein | Ofte (30–79 %) | I 1 tilstand |
| TBK1TANK binding kinase 1 | Ofte (30–79 %) | I 2 tilstander |
| TBL1XR1TBL1X/Y related 1 | Ofte (30–79 %) | I 1 tilstand |
| TBX20T-box transcription factor 20 | Ofte (30–79 %) | I 1 tilstand |
| TCAPtitin-cap | Ofte (30–79 %) | I 1 tilstand |
| TERCtelomerase RNA component | Ofte (30–79 %) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Ofte (30–79 %) | I 1 tilstand |
| TICAM1TIR domain containing adaptor molecule 1 | Ofte (30–79 %) | I 1 tilstand |
| TLL1tolloid like 1 | Ofte (30–79 %) | I 2 tilstander |
| TLR3toll like receptor 3 | Ofte (30–79 %) | I 1 tilstand |
| TMEM126Btransmembrane protein 126B | Ofte (30–79 %) | I 1 tilstand |
| TMEM127transmembrane protein 127 | Ofte (30–79 %) | I 1 tilstand |
| TMPOthymopoietin | Ofte (30–79 %) | I 1 tilstand |
| TNNC1troponin C1, slow skeletal and cardiac type | Ofte (30–79 %) | I 1 tilstand |
| TNNI3troponin I3, cardiac type | Ofte (30–79 %) | I 1 tilstand |
| TNNT2troponin T2, cardiac type | Ofte (30–79 %) | I 1 tilstand |
| TNXBtenascin XB | Ofte (30–79 %) | I 1 tilstand |
| TPM1tropomyosin 1 | Ofte (30–79 %) | I 1 tilstand |
| TPM2tropomyosin 2 | Ofte (30–79 %) | I 2 tilstander |
| TPM3tropomyosin 3 | Ofte (30–79 %) | I 1 tilstand |
| TRAF3TNF receptor associated factor 3 | Ofte (30–79 %) | I 1 tilstand |
| TREM2triggering receptor expressed on myeloid cells 2 | Ofte (30–79 %) | I 1 tilstand |
| TRHRthyrotropin releasing hormone receptor | Ofte (30–79 %) | I 2 tilstander |
| TRIOtrio Rho guanine nucleotide exchange factor | Ofte (30–79 %) | I 1 tilstand |
| TSHBthyroid stimulating hormone subunit beta | Ofte (30–79 %) | I 1 tilstand |
| TTNtitin | Ofte (30–79 %) | I 2 tilstander |
| TWNKtwinkle mtDNA helicase | Ofte (30–79 %) | I 2 tilstander |
| TXNRD2thioredoxin reductase 2 | Ofte (30–79 %) | I 1 tilstand |
| UBQLN2ubiquilin 2 | Ofte (30–79 %) | I 1 tilstand |
| UNC13Aunc-13 homolog A | Ofte (30–79 %) | I 1 tilstand |
| UNC93B1unc-93B1 regulator of TLR signaling | Ofte (30–79 %) | I 1 tilstand |
| USH2Ausherin | Ofte (30–79 %) | I 1 tilstand |
| VAPBVAMP associated protein B and C | Ofte (30–79 %) | I 2 tilstander |
| VCLvinculin | Ofte (30–79 %) | I 1 tilstand |
| VCPvalosin containing protein | Ofte (30–79 %) | I 1 tilstand |
| VEZF1vascular endothelial zinc finger 1 | Ofte (30–79 %) | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Ofte (30–79 %) | I 3 tilstander |
| WASWASP actin nucleation promoting factor | Ofte (30–79 %) | I 1 tilstand |
| WHRNwhirlin | Ofte (30–79 %) | I 1 tilstand |
| ZBTB16zinc finger and BTB domain containing 16 | Ofte (30–79 %) | I 1 tilstand |
| ABCC2ATP binding cassette subfamily C member 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ACADMacyl-CoA dehydrogenase medium chain | Noen ganger (5–29 %) | I 1 tilstand |
| ADAMTS2ADAM metallopeptidase with thrombospondin type 1 motif 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ADAMTSL2ADAMTS like 2 | Noen ganger (5–29 %) | I 1 tilstand |
| AP2S1adaptor related protein complex 2 subunit sigma 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ARNT2aryl hydrocarbon receptor nuclear translocator 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ASCC3activating signal cointegrator 1 complex subunit 3 | Noen ganger (5–29 %) | I 1 tilstand |
| C1QBPcomplement C1q binding protein | Noen ganger (5–29 %) | I 1 tilstand |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Noen ganger (5–29 %) | I 1 tilstand |
| COL1A2collagen type I alpha 2 chain | Noen ganger (5–29 %) | I 1 tilstand |
| EPB41erythrocyte membrane protein band 4.1 | Noen ganger (5–29 %) | I 1 tilstand |
| FGFR1fibroblast growth factor receptor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| FTLferritin light chain | Noen ganger (5–29 %) | I 1 tilstand |
| GIMAP5GTPase, IMAP family member 5 | Noen ganger (5–29 %) | I 1 tilstand |
| GPR35G protein-coupled receptor 35 | Noen ganger (5–29 %) | I 1 tilstand |
| GRM1glutamate metabotropic receptor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| GYPCglycophorin C (Gerbich blood group) | Noen ganger (5–29 %) | I 1 tilstand |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Noen ganger (5–29 %) | I 1 tilstand |
| IGHG2immunoglobulin heavy constant gamma 2 (G2m marker) | Noen ganger (5–29 %) | I 1 tilstand |
| IGKCimmunoglobulin kappa constant | Noen ganger (5–29 %) | I 1 tilstand |
| IL12RB1interleukin 12 receptor subunit beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| KPNA3karyopherin subunit alpha 3 | Noen ganger (5–29 %) | I 1 tilstand |
| MMEL1membrane metalloendopeptidase like 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MST1macrophage stimulating 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Noen ganger (5–29 %) | I 1 tilstand |
| MYD88MYD88 innate immune signal transduction adaptor | Noen ganger (5–29 %) | I 1 tilstand |
| NAB2NGFI-A binding protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| NAGSN-acetylglutamate synthase | Noen ganger (5–29 %) | I 1 tilstand |
| NAXENAD(P)HX epimerase | Noen ganger (5–29 %) | I 1 tilstand |
| PGM1phosphoglucomutase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PHEXphosphate regulating endopeptidase X-linked | Noen ganger (5–29 %) | I 1 tilstand |
| PHKA2phosphorylase kinase regulatory subunit alpha 2 | Noen ganger (5–29 %) | I 2 tilstander |
| PHKBphosphorylase kinase regulatory subunit beta | Noen ganger (5–29 %) | I 1 tilstand |
| PHKG2phosphorylase kinase catalytic subunit gamma 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PLECplectin | Noen ganger (5–29 %) | I 1 tilstand |
| POU2AF1POU class 2 homeobox associating factor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PPP2R5Dprotein phosphatase 2 regulatory subunit B'delta | Noen ganger (5–29 %) | I 1 tilstand |
| PROKR2prokineticin receptor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PYGMglycogen phosphorylase, muscle associated | Noen ganger (5–29 %) | I 1 tilstand |
| RHAGRh associated glycoprotein | Noen ganger (5–29 %) | I 1 tilstand |
| SEMA4Dsemaphorin 4D | Noen ganger (5–29 %) | I 1 tilstand |
| SIsucrase-isomaltase | Noen ganger (5–29 %) | I 1 tilstand |
| SIN3ASIN3 transcription regulator family member A | Noen ganger (5–29 %) | I 1 tilstand |
| SLC40A1solute carrier family 40 member 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SOX2SRY-box transcription factor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| SPIBSpi-B transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| SPTA1spectrin alpha, erythrocytic 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SPTBspectrin beta, erythrocytic | Noen ganger (5–29 %) | I 1 tilstand |
| STAT1signal transducer and activator of transcription 1 | Noen ganger (5–29 %) | I 1 tilstand |
| STAT6signal transducer and activator of transcription 6 | Noen ganger (5–29 %) | I 1 tilstand |
| TCF4transcription factor 4 | Noen ganger (5–29 %) | I 1 tilstand |
| TNFSF15TNF superfamily member 15 | Noen ganger (5–29 %) | I 1 tilstand |
| TNPO3transportin 3 | Noen ganger (5–29 %) | I 1 tilstand |
| TSC1TSC complex subunit 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TSC2TSC complex subunit 2 | Noen ganger (5–29 %) | I 1 tilstand |
| UNC45Bunc-45 myosin chaperone B | Noen ganger (5–29 %) | I 1 tilstand |
| YY1YY1 transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| DNM1Ldynamin 1L | Sjelden (1–4%) | I 1 tilstand |
| PPIBpeptidylprolyl isomerase B | Sjelden (1–4%) | I 1 tilstand |
| SPTBN1spectrin beta, non-erythrocytic 1 | Sjelden (1–4%) | I 1 tilstand |
| AGKacylglycerol kinase | Ikke registrert | I 1 tilstand |
| APTXaprataxin | Ikke registrert | I 1 tilstand |
| ARMC5armadillo repeat containing 5 | Ikke registrert | I 1 tilstand |
| CAV3caveolin 3 | Ikke registrert | I 1 tilstand |
| CD244CD244 molecule | Ikke registrert | I 1 tilstand |
| CIITAclass II major histocompatibility complex transactivator | Ikke registrert | I 1 tilstand |
| COQ2coenzyme Q2, polyprenyltransferase | Ikke registrert | I 1 tilstand |
| DYSFdysferlin | Ikke registrert | I 1 tilstand |
| NFKBIL1NFKB inhibitor like 1 | Ikke registrert | I 1 tilstand |
| POMGNT1protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | Ikke registrert | I 1 tilstand |
| SERPINA6serpin family A member 6 | Ikke registrert | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Ikke registrert | I 1 tilstand |
| SLC18A3solute carrier family 18 member A3 | Ikke registrert | I 1 tilstand |
| SLC22A4solute carrier family 22 member 4 | Ikke registrert | I 1 tilstand |
| SLC25A26solute carrier family 25 member 26 | Ikke registrert | I 1 tilstand |
| TFR2transferrin receptor 2 | Ikke registrert | I 1 tilstand |
| UBA1ubiquitin like modifier activating enzyme 1 | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker